Aquestive Therapeutics, Inc. AQST Other Receivables, Gross
Other Receivables, Gross at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherReceivablesGrossCurrent.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s other receivables, gross.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s other receivables, gross?
- Aquestive Therapeutics, Inc. (AQST) reported other receivables, gross of $1.61M in Q1 2026.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s other receivables, gross?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s other receivables, gross has grown at a 25.9% compound annual growth rate (CAGR), from $3.08M to $9.75M.
- What does other receivables, gross mean?
- This represents the total amount of miscellaneous receivables owed to the company from non-trade sources, prior to any adjustments for potential credit losses. It captures claims for cash or other assets that are not directly related to the sale of core goods or services. Monitoring this helps identify potential liquidity tied up in non-operating assets.